期刊名称：GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Graefe's Archive for Clinical and Experimental Ophthalmology is a distinguished international journal that presents original clinical reports and clini-cally relevant experimental studies.
Founded in 1854 by Albrecht von Graefe to serve as a source of useful clinical information and a stimulus for discussion, the journal has published articles by leading ophthalmologists and vision research scientists for more than a century. With peer review by an international Editorial Board and prompt English-language publication, Graefe's Archive provides rapid dissemination of clinical and clinically related experimental information. |
 |
Instructions to Authors
Legal Requirements
The author(s) guarantee(s) that the manuscript will not be published elsewhere in any language without the consent of the copyright holders, that the rights of third parties will not be violated, and that the publisher will not be held legally responsible should there be any claims for compensation.
Authors wishing to include figures or text passages that have already been published elsewhere are required to obtain permission from the copyright holder(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Open Choice Publication
In addition to the normal publication process (whereby an article is submitted to the journal and access to that article is granted to customers who have purchased a subscription), Springer now provides and alternative publishing option: Spriner Open Choice. A Springer Open Choice article receives all the benefits of a regular “subscription-based” article, but in addition is made available publicly through Springer’s online platform SpringerLink. To publish via Springer Open Choice, upon acceptance please visit the link below to complete the relevant order form and provide the required payment information. Payment must be reveived in full before publication or articles will be published as regular subscription-model articles. We regret that Springer Open Choice cannot be orderd for published articles.
General
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.
Reports of animal experiments must state that the “Principles of laboratory animal care” (NIH publication No. 85–23, revised 1985), the OPRR Public Health Service Policy on the Humane Care and Use of Laboratory Animals (revised 1986) and the U.S. Animal Welfare Act, as amended, were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.
Ocular Trauma Terminology. Terminology used in descriptions of ocular trauma should conform to the recommendations of the United States Eye Injury Registry and the International Society of Ocular Trauma Birmingham Eye Trauma Terminology (BETT): Kuhn F, Morris R, Witherspoon D, et al. (1996) A standard classification of ocular trauma. Graefe’s Arch 234:399–403.
Nomenclature for Ophthalmic Malignancies. Authors should use the American Joint Commission on Cancer TNM classification scheme when describing patients with ophthalmic malignancies (American Joint Commission on Cancer. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009).
The Editor-in-Chief reserves the right to reject manuscripts that do not comply with the above mentioned requirements. The author will be held responsible for false statements or for failure to fulfill the above-mentioned requirements.
Rejection by another journal will not compromise in any way the processing of a submission. The editorial office recommends that this should be mentioned on the cover letter.
Conflicts of opinion-you may mention up to 3 institutes/individuals with whom you have a conflict of opinion.
Editorial procedure
Manuscripts should be submitted in English, one original and two duplicates to the Editor-in-Chief
Prof. B. Kirchhof (for address see page A3). Please be sure to include your e-mail ad-dress
and your fax number. Senior co-authors should note that they have the responsibility to
read and edit manuscripts bearing their name.
Manuscripts not found suitable for publication will be destroyed by the Editorial office, figures
and referees comments will be sent by surface mail. Please do not transmit electronic data to
the publisher until your manuscript has been reviewed and accepted for publication. Please
follow successional instructions.
Manuscript preparation
General remarks
To help you prepare your manuscript, Springer offers a template that can be used with
Winword 7 (Windows 95), Winword 6 and Word for Macintosh. For details see Electronic
Submission of final version.
Papers should not exceed 7 printed pages.
Three manuscript pages equal approximately one printed page. The space required for the
figures and tables should be calculated on the basis of their final printed size. All accepted
manuscripts will be copy-edited.
Title page
- A concise and informative title
- Full name and surname of each author
- Affiliation(s) and address(es) of each author
- E-mail address, snail mail address, telephone and fax numbers of the corresponding author
- Notes indicating whether or not a financial relationship with the organisation that sponsored the research exists. This can be in the from of Grants, Equipment or Drugs or all of these. It must be stated that the authors have full control of all primary data and they agree to allow Graefes Archive for Clinical and Experimental Ophthalmology to review their data upon request. Clinical Trials registration reference number.
Abstract. A summary of the most important results and conclusions in no more than 250 words. The abstract must be devided into and C four sections: Background, Methods, Results onclusions.
Footnotes. Essential footnotes to the text should be numbered consecutively and placed
at the bottom of the page to which they refer.
Footnotes on the title page are not given reference symbols. Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters(or asterisks for significance values and other statistical data).
Introduction. The Introduction should state the purpose of the investigation and give a
short review of the pertinent literature (max.one printed page).
Materials and methods The Materials and
Methods section should follow the Introduction and should provide enough information to
permit repetition of the experimental work. For particular chemicals or equipment, the
name and location of the supplier should be given in parentheses.
Results. The Results section should describe the outcome of the study. Data should be pre-sented
as concisely as possible, if appropriate in the form of tables or figures, although very large tables should be avoided.
Discussion. The Discussion should be an inter-pretation of the results and their significance with reference to work by other authors.
Acknowledgements. These should be as brief as possible. Any grant that requires acknow-ledgement should be mentioned. The names of funding organizations should be written in
full.
Appendices. If there is more than one appendix, they should be numbered consecutively.
Equations in appendices should be designated differently from those in the main body of the
paper, e.g. (A1), (A2) etc. In each appendix equations should be numbered separately.
References
The list of References should only include works that are cited in the text and have been previously published or accepted for publication. Personal communications should only be mentioned in the text. Papers which have been accepted for publication but not yet published should be included in the list of references with the name of the journal and the Digital Object Identifier (DOI) code of the cited literature. The author is responsible for the accuracyof the references. Journal articles
Grissom LE, Harcke HT (1997) Ultrasono-graphy of nondevelopmental dysplasia of the
hips. Pediatr Radiol 27: 70-74
Dyall KG (1998) Relative and non-relative finite nucleus optimized double zeta basis sets
for the elements. Theor Chem Acc 99: 366¨C371. DOI 10.1007/s002149800025
Dyall KG (in press) Relative and nonrelative finite nucleus optimized double zeta basis sets
for the elements. Theor Chem Acc DOI 10.1007/s002149800025
Books
Larcher W (1995) Physiological plant ecology, 3rd edn. Springer, Berlin Heidelberg New York
Multiauthor books
Hovind HJ (1986) Traumatic birth injuries. In: Raimondi AJ, Choux M, Di Rocco C
(eds) Head injuries in the newborn and infant. (Principles of pediatric neurosurgery)
Springer, Berlin Heidelberg New York, pp 87¨C109
Illustrations and Tables
- All figures (photographs, graphs or diagrams) and tables should be cited in the text, and each numbered consecutively throughout. Lowercase letters (a, b etc.) should be used to identify figure parts. If illustrations are supplied with uppercase labeling, lowercase letters will still be used in the figure legends and citations. The placement of figures and tables should be indicated in the left margin.
Line drawings
- Please submit good-quality files. The inscriptions should be clearly legible.
Half-tone illustrations
- Please submit wellcontrasted photographic files. Magnification should be indicated by scale bars.
Plates
- Several figures or figure parts should be grouped in a plate on one page.
Size of figures
- The figures should either match the width of the column (8.4 cm) or be 12.9 cm or 17.4 cm wide. The maximum length is 23.4 cm.
Figure legends
- Figure legends should be brief, self-sufficient explanations of the illustrations. The legends should be placed at the end of the text.
Tables
- Tables should have a legend that includes the title of the table and an explanation of any abbreviations used in that table. Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data).
Colour illustrations
- There is no extra charge for colour illustrations or figures.
Further information and a manuscript checklist can be found on the editorial office home page:
Editorial Office
D. Epstein
Di-Ep Biomedical Editorial Services
10 Sandyford Place
Glasgow G3-7NB
Scotland, UK
Fax +44-141-6169095
e-mail: graefes_archive@di-ep.com
Proofreading
Authors should make their proof corrections on a printout of the pdf file supplied or use the online correction facilities provided with the proofs, checking that the text is complete and that all figures and tables are included. After online publication, further changes can only be made in the form of an Erratum, which will be hyperlinked to the article. The author is entitled to formal corrections only. Substantial changes in content, e.g. new results, corrected values, title and authorship are not allowed without the approval of the responsible editor. In such a case please contact the Editorial Office before returning the proofs to the publisher.
Offprints, Free Copy
One complimentary copy is supplied. Offprints are available at cost price, provided the order form is returned together with the corrected page proofs.
Editorial Board
Editor-in-Chief
B. Kirchhof
Universitäts-Augenklinik Köln
Editorial Manager
D. Epstein
Universitäts-Augenklinik Köln
Joseph-Stelzmann-Strasse 9
50931 Köln, Germany
Fax: +49-221-4783187
e-mail: gra.arc@medizin.uni-koeln.de
| 
